PRESERVATION OF LIVER SPHEROIDS

Information

  • Research Project
  • 7107042
  • ApplicationId
    7107042
  • Core Project Number
    R43ES013609
  • Full Project Number
    1R43ES013609-01A2
  • Serial Number
    13609
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/2006 - 18 years ago
  • Project End Date
    12/31/2007 - 16 years ago
  • Program Officer Name
    DENSMORE, CHRISTINE L.
  • Budget Start Date
    7/1/2006 - 18 years ago
  • Budget End Date
    12/31/2007 - 16 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
    A2
  • Award Notice Date
    6/30/2006 - 18 years ago

PRESERVATION OF LIVER SPHEROIDS

[unreadable] DESCRIPTION (provided by applicant): Assays are being developed in efforts to reduce the number of animals required for research. In particular, cell based systems that can evaluate a variety of compounds and/or screen single compounds with many cell types would provide the most advantageous platforms. These types of assay systems would be applicable to drug discovery, toxicology testing and environmental screening. While many cell types can be used in these systems, there are some cell types that are more relevant. Hepatocytes are one such cell type. However, their functions in culture become compromised very quickly and they have not been particularly amenable to cryopreservation when frozen as individual cells either in suspension or as a monolayer. Hepatocytes will aggregate in culture forming spheroids and studies have shown that spheroids maintain their specific functions longer in culture than freshly isolated hepatocytes. Therefore, spheroids have wide applicability for many different assay systems. Even better would be preserved spheroids that could be used whenever they were needed. To date, only one published study has been performed evaluating liver spheroids after cryopreservation. In the current study, both freezing and vitrification cryopreservation methods for liver spheroids will be developed using primary hepatocytes from rats. Freezing involves preservation with formation of ice. A protocol derived from studies cryopreserving hepatocytes will be employed. Vitrification is an ice-free preservation method that has been used successfully in some tissues. Two vitrification solutions and two rewarming methods will be evaluated using two non-specific viability assays and two liver cell-specific function assays. Either approach could prove successful and the goal of this study is to demonstrate viability and specific function of liver spheroids by either method. Phase II studies will involve optimization for the best method of cryopreservation by either freezing or vitrification in anticipation of commercialization of mammalian liver spheroids. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
  • Activity
    R43
  • Administering IC
    ES
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    147863
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    114
  • Ed Inst. Type
  • Funding ICs
    NIEHS:147863\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CELL AND TISSUE SYSTEMS, INC.
  • Organization Department
  • Organization DUNS
    175100333
  • Organization City
    NORTH CHARLESTON
  • Organization State
    SC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    29406
  • Organization District
    UNITED STATES